Search results
RBC maintains Biogen Outperform stock rating, awaits Leqembi sales acceleration By Investing.com
Investing.com· 22 hours agoOn Wednesday, RBC Capital expressed continued confidence in Biogen (NASDAQ:BIIB), maintaining an...
UPCOMING DEADLINE ALERT: Biogen Inc. (Nasdaq: BIIB) Investors are Encouraged to Contact BFA Law...
Morningstar· 16 hours agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities ...
...That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages...
Morningstar· 11 hours agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class...
Morningstar· 1 day agoNEW YORK, June 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB). Shareholders who purchased shares of BIIB during the class period listed are encouraged
Biogen Inc London Stock Price Today | NASDAQ 0R1B Live Ticker - Investing.com
Investing.com· 2 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 2 days agoGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB) Glancy Prongay & Murray LLP (“GPM”) reminds investors ...
Biogen stock favored at RBC as Lilly awaits Alzheimer’s drug
Seeking Alpha· 18 hours agoRBC Capital Markets maintains a bullish view on Biogen (BIIB) despite Eli Lilly's (LLY) upcoming FDA...
FINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with...
Morningstar· 20 hours agoLOS ANGELES, June 5, 2024 /PRNewswire/ -- , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen ...
European Commission grants marketing approval to Biogen's ALS drug
Reuters· 7 days ago, opens new tab said on Thursday that the European Commission has granted marketing authorization...
Novartis and others face Italy antitrust probe over eye drug
Reuters· 4 hours agoSamsung Bioepis, Biogen, Genentech and Novartis, and some of their Italian, Dutch and UK units,...